Rapt Therapeutics EPS Basic from Extraordinaries (Quarterly) Insights

Rapt Therapeutics, Inc. (RAPT)

33.74 -0.66 (-1.92%) USD | NASDAQ | Jan 13, 13:10

View EPS Basic from Extraordinaries (Quarterly) for RAPT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Extraordinaries (Quarterly) Benchmarks

Start Trial

Replimune Group, Inc.	--
Olema Pharmaceuticals, Inc.	--
NovaBay Pharmaceuticals, Inc.	--
Palatin Technologies, Inc.	--
Theriva Biologics, Inc.	--